Prevention of mother-to-child transmission in South Africa: an ever-changing landscape
- PMID: 27512452
- PMCID: PMC4934997
- DOI: 10.1177/1753495X15570994
Prevention of mother-to-child transmission in South Africa: an ever-changing landscape
Abstract
Almost 30% of pregnant women attending public health clinics in South Africa are HIV positive; which represents approximately 280,000 women each year. South Africa has the largest antiretroviral therapy programme in the world, with over 2.7 million people on treatment in 2013. Since its belated and controversial beginning, the Prevention of Mother-to-Child Transmission programme has achieved a substantial reduction in vertical transmission. South Africa is justifiably proud of this success. However, the history of Prevention of Mother-to-Child Transmission (PMTCT) and antiretroviral therapy programmes in South Africa has been fraught with delays and political intervention. South Africa could have started both PMTCT and antiretroviral therapy programmes in 2000. Instead, the AIDS denialist views of the government allowed the HIV epidemic to spiral out of control. Roll-out of a national PMTCT programme began in 2002, but only after the government was forced to do so by a Constitutional Court ruling. Now, a decade later, HIV treatment and prevention programmes have been completely transformed. This article will discuss the evolution of the HIV epidemic in South Africa, and give a historical overview of the struggle to establish a national PMTCT, and the impact of delaying PMTCT and treatment programmes on infant and maternal health.
Keywords: AIDS; HIV; complications; drugs (medication); infectious diseases; maternal child transmission; maternal mortality; maternal-fetal medicine.
Figures
References
-
- National Department of Health. The 2012 National Antenatal Sentinel HIV & Herpes Simplex Type-2 Prevalence Survey in South Africa. Report. Pretoria, 2014.
-
- UNAIDS. Getting to zero: HIV in Eastern and Southern Africa. Report. Johannesburg, 2013.
-
- Chigwedere P, Seage GR, III, Gruskin S, et al. Estimating the lost benefits of antiretroviral drug use in South Africa. JAIDS 2008; 49: 410–415. - PubMed
-
- Mayosi BM, Lawn JE, van Niekerk A, et al. Health in South Africa: changes and challenges since 2009. Lancet 2012; 380: 2029–2043. - PubMed
Publication types
LinkOut - more resources
Full Text Sources